View Full Profile. Learn about our Editorial Policies. Cancer therapy pioneer John Mendelsohn died from glioblastoma, an aggressive form of brain cancer, on Monday (January 7). He was 82. Mendelsohn ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Nicola Mendelsohn was diagnosed with an incurable form of blood cancer in 2016, and has since returned to work. How is the Facebook executive navigating a demanding career when her personal life ...

A new UCLA study has found that artificial intelligence could help doctors identify prostate cancer patients most ...

Patients then receive the therapeutic component of Pluvicto, which attaches to the cancer cells via the same antigen target and emits radiation to kill their DNA. UCLA Health’s Outpatient ...

UCLA co-led study is first trial analyzing a targeted therapy drug specifically made for brain tumors. In an international study co-led by UCLA Health Jonsson Comprehensive Cancer Center ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...